Serum GlycA level is a candidate biomarker for disease activity in systemic lupus erythematosus and for proliferative status of lupus nephritis, independent of renal function impairment.
T. Dierckx, S. Goletti, L. Chiche, L. Daniel, B. Lauwerys, N. Jourde-Chiche, J. Van Weyenbergh
This study shows Serum GlycA is elevated in systemic lupus erythematosus and correlates with disease activity and lupus nephritis, outperforming traditional biomarkers in predicting proliferative LN.
bioRxiv · Dec 12, 2018 · PreprintImmunology